FDA Approved: CIMDUO — Original Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved CIMDUO, a fixed-dose combination of lamivudine and tenofovir disoproxil fumarate, in an original application by Viatris Specialty LLC for the treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CIMDUO (LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

ORIG AP for CIMDUO (LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE)